Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2021-08-09 5:17 pm Purchase | 13G | DA32 LIFE SCIENCE TECH ACQUISI DALS | RA CAPITAL MANAGEMENT L.P. | 1,500,000 7.3% | 1,500,000 (New Position) | View |
| 2021-08-09 4:32 pm Purchase | 13G | TENAYA THERAPEUTICS INC TNYA | RA CAPITAL MANAGEMENT L.P. | 3,551,508 8.6% | 3,551,508 (New Position) | View |
| 2021-08-06 4:30 pm Purchase | 13D | CYTEK BIOSCIENCES INC CTKB | RA CAPITAL MANAGEMENT L.P. | 9,607,028 7.2% | 9,607,028 (New Position) | View |
| 2021-07-28 4:30 pm Purchase | 13G | TSCAN THERAPEUTICS INC TCRX | RA CAPITAL MANAGEMENT L.P. | 1,255,317 6.7% | 1,255,317 (New Position) | View |
| 2021-07-23 4:30 pm Purchase | 13G | ARYA SCIENCES ACQUISITION CORP ARYE | RA CAPITAL MANAGEMENT L.P. | 1,000,000 6.5% | 1,000,000 (New Position) | View |
| 2021-07-20 4:31 pm Purchase | 13G | POINT BIOPHARMA GLOBAL INC PNT | RA CAPITAL MANAGEMENT L.P. | 8,856,018 9.8% | 8,856,018 (New Position) | View |
| 2021-07-16 4:30 pm Purchase | 13D | ACUMEN PHARMACEUTICALS INC ABOS | RA CAPITAL MANAGEMENT L.P. | 9,770,773 25.3% | 9,770,773 (New Position) | View |
| 2021-07-12 5:13 pm Purchase | 13D | AEROVATE THERAPEUTICS INC AVTE | RA CAPITAL MANAGEMENT L.P. | 8,263,982 33.9% | 8,263,982 (New Position) | View |
| 2021-07-12 4:30 pm Purchase | 13G | AERPIO PHARMACEUTICALS INC ARPO | RA CAPITAL MANAGEMENT L.P. | 1,574,806 3.3% | 1,574,806 (New Position) | View |
| 2021-07-09 4:31 pm Purchase | 13G | GH RESH PLC SHS GHRS | RA CAPITAL MANAGEMENT L.P. | 2,978,955 5.9% | 2,978,955 (New Position) | View |
| 2021-06-30 4:33 pm Purchase | 13G | ENTERA BIO LTD SHS ENTX | RA CAPITAL MANAGEMENT L.P. | 2,353,000 9.9% | 2,353,000 (New Position) | View |
| 2021-06-30 4:32 pm Purchase | 13D | THERAPEUTICS ACQUISITION CORP RACA | RA CAPITAL MANAGEMENT L.P. | 1,098,318 7.8% | 1,098,318 (New Position) | View |
| 2021-06-29 4:33 pm Purchase | 13G | CYTEIR THERAPEUTICS INC CYT | RA CAPITAL MANAGEMENT L.P. | 3,247,117 9.4% | 3,247,117 (New Position) | View |
| 2021-06-21 4:45 pm Unchanged | 13G | NOVAN INC NOVN | RA CAPITAL MANAGEMENT L.P. | 0 0% | 0 (Unchanged) | View |
| 2021-06-16 5:20 pm Purchase | 13D | JANUX THERAPEUTICS INC JANX | RA CAPITAL MANAGEMENT L.P. | 8,670,644 20.8% | 8,670,644 (New Position) | View |
| 2021-06-16 4:59 pm Purchase | 13D | WEREWOLF THERAPEUTICS INC HOWL | RA CAPITAL MANAGEMENT L.P. | 4,291,881 15.6% | 323,298 (+8.15%) | View |
| 2021-06-15 4:32 pm Purchase | 13G | ASTRIA THERAPEUTICS INC ATXS | RA CAPITAL MANAGEMENT L.P. | 5,745,744 7.5% | 5,745,744 (New Position) | View |
| 2021-06-07 5:12 pm Purchase | 13D | CONNECT BIOPHARMA HLDGS LTD CNTB | RA CAPITAL MANAGEMENT L.P. | 6,991,003 12.2% | 350,586 (+5.28%) | View |
| 2021-06-07 4:48 pm Purchase | 13G | DAY ONE BIOPHARMACEUTICALS INC DAWN | RA CAPITAL MANAGEMENT L.P. | 4,965,588 8% | 4,965,588 (New Position) | View |
| 2021-06-04 4:32 pm Purchase | 13D | 89BIO INC ETNB | RA CAPITAL MANAGEMENT L.P. | 4,965,769 24.8% | 229,555 (+4.85%) | View |